Bioequivalence and Bioavailability Forum

Subject	Category	Author	posted	Replies	last R.	Views
⚠️ Read before registering 📌	Tips / Tricks	Helmut	2016-04-14 23:39	0		138,437
Three-way crossover BABE Studies Three-way crossover example data set Three-way crossover example data set Three-way crossover example data set Three-way crossover (WinNonlin) Three-way crossover (WinNonlin) Three-way crossover (WinNonlin) Three-way crossover (WinNonlin) Three-way crossover example data set Three-way crossover example data set Three-way crossover example data set Three-way crossover example data set Leave-One-Out (IBD) Leave-One-Out (IBD) Impact of pooled variance (bias, CI) carry (over?) Pseudo-periods Pseudo-periods Two‐at‐a‐Time analysis in R fixed & mixed (dammit!) and a request to SASians Pooled vs IBD T-R in SAS from non-SASian Pooled vs IBD T-R in SAS from non-SASian mixed in R mixed in R (EMA B ≠ FDA) Williams design 3-way Williams design 3-way Williams design 3-way Williams design 3-way Williams design 3-way Williams design 3-way Williams design 3-way Williams design 3-way Williams design 3-way Period effects in general Williams design 3-way	Design Issues	acfalcao	2007-09-16 22:34	34	2021-06-11 16:56	24,796
DDSolver Issue DDSolver Issue DDSolver Issue DDSolver Issue DDSolver Issue	General Statistics	Laszlo Istvan Orosz	2021-06-09 14:12	4	2021-06-11 09:51	152
Number of sets selection in In-Vitro Kinetic and Equilibrium Binding study	Regulatives / Guidelines	Sivakrishna	2021-06-10 08:12	0		102
Food effects Food effects	Design Issues	prasad.v	2021-06-08 08:35	1	2021-06-09 06:06	191
Guidelines Guidelines Guidelines	Regulatives / Guidelines	RAMS69	2021-06-04 03:46	2	2021-06-09 04:43	277
Impact of COVID-19 on HV trials Impact of COVID-19 on HV trials Impact of COVID-19 on HV trials Impact of COVID-19 on HV trials Impact of COVID-19 on HV trials	Study Performance	Silvia Giarcovich	2020-04-16 22:38	4	2021-06-03 06:06	3,144
Registration with CTRI Registration with CTRI	Regulatives / Guidelines	surajpatel	2021-06-02 07:30	1	2021-06-02 11:39	189
AUC from 0 to tau at steady state AUC from 0 to tau at steady state AUC from 0 to tau at steady state	NCA / SHAM	martin	2021-06-01 14:43	2	2021-06-01 22:13	352
Dose normalization Dose normalization Dose normalization Dose normalization Dose normalization	Study Performance	Yura	2021-05-27 12:25	4	2021-06-01 09:23	371
AUCrefTmax AUCrefTmax (Health Canada) AUCrefTmax (Health Canada) AUCrefTmax (Health Canada) AUCrefTmax (Health Canada)	Regulatives / Guidelines	raghup	2021-05-28 12:44	4	2021-05-31 10:15	290
partial AUCs for locally acting MR partial AUCs for locally acting MR partial AUCs for locally acting MR partial AUCs for locally acting MR	Design Issues	Susanh	2020-12-04 16:14	3	2021-05-31 08:47	1,108
Exclusion of Outlier Data Exclusion of Outlier Data Health Canada: read the guidance	Outliers	surajpatel	2021-05-27 08:14	2	2021-05-27 10:14	260
bioequivalence if test and reference formulation having different strengths least common multiple of T and R least common multiple of T and R least common multiple of T and R least common multiple of T and R	Design Issues	Vishal S	2021-05-24 09:21	4	2021-05-26 00:23	558
High post-hoc power…	Power / Sample Size	Helmut	2021-05-20 23:33	0		302